相似文献
1
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.
Vaccine. 2010 Jul 12;28(31):5017-22. doi: 10.1016/j.vaccine.2010.05.018. Epub 2010 May 21.
2
Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
BMC Microbiol. 2006 Aug 9;6:71. doi: 10.1186/1471-2180-6-71.
3
Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
J Microbiol Immunol Infect. 2016 Jun;49(3):352-8. doi: 10.1016/j.jmii.2014.05.008. Epub 2014 Jul 30.
4
Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
Vaccine. 2017 Jan 3;35(1):19-26. doi: 10.1016/j.vaccine.2016.11.065. Epub 2016 Nov 24.
5
Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.
Vaccine. 2007 Feb 26;25(10):1789-97. doi: 10.1016/j.vaccine.2006.11.031. Epub 2006 Nov 30.
6
Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.
Microbiol Immunol. 2018 Jun;62(6):395-404. doi: 10.1111/1348-0421.12595. Epub 2018 Jun 11.
7
Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
Vaccine. 2002 Jun 21;20(21-22):2816-25. doi: 10.1016/s0264-410x(02)00205-0.
8
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
J Infect Dis. 2006 Jun 15;193(12):1666-76. doi: 10.1086/504266. Epub 2006 May 10.
9
Structural optimisation of a conformational epitope improves antigenicity when expressed as a recombinant fusion protein.
Vaccine. 2009 Nov 12;27(48):6799-806. doi: 10.1016/j.vaccine.2009.08.049. Epub 2009 Sep 1.
10
Group A streptococcus expresses a trio of surface proteins containing protective epitopes.
Clin Vaccine Immunol. 2014 Oct;21(10):1421-5. doi: 10.1128/CVI.00448-14. Epub 2014 Jul 30.
引用本文的文献
1
Conserved molecular chaperone PrsA stimulates protective immunity against group A Streptococcus.
NPJ Vaccines. 2024 Feb 26;9(1):46. doi: 10.1038/s41541-024-00839-7.
2
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.
Nat Commun. 2023 Sep 25;14(1):5963. doi: 10.1038/s41467-023-41410-7.
3
Naturally acquired functional antibody responses to group A differ between major strain types.
mSphere. 2023 Oct 24;8(5):e0017923. doi: 10.1128/msphere.00179-23. Epub 2023 Sep 20.
4
Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine.
Vaccine. 2023 Sep 15;41(40):5841-5847. doi: 10.1016/j.vaccine.2023.08.026. Epub 2023 Aug 16.
5
Serum Immune Responses to Group A Streptococcal Antigens following Pharyngeal Acquisitions among Children in Cape Town, South Africa.
mSphere. 2023 Jun 22;8(3):e0011323. doi: 10.1128/msphere.00113-23. Epub 2023 May 8.
6
New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus.
Asian J Pharm Sci. 2022 May;17(3):435-446. doi: 10.1016/j.ajps.2022.04.002. Epub 2022 Apr 30.
7
Utility of Human Immune Responses to GAS Antigens as a Diagnostic Indicator for ARF: A Systematic Review.
Front Cardiovasc Med. 2021 Jul 20;8:691646. doi: 10.3389/fcvm.2021.691646. eCollection 2021.
8
Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal Vaccines.
J Immunol. 2021 Aug 15;207(4):1138-1149. doi: 10.4049/jimmunol.2100286. Epub 2021 Aug 2.
9
Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
Vaccine. 2021 Mar 19;39(12):1773-1779. doi: 10.1016/j.vaccine.2021.01.075. Epub 2021 Feb 26.
10
Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from Mutant Streptococcus pyogenes.
mBio. 2021 Feb 23;12(1):e03537-20. doi: 10.1128/mBio.03537-20.
本文引用的文献
1
STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS.
J Exp Med. 1919 Sep 1;30(3):179-213. doi: 10.1084/jem.30.3.179.
2
Group A streptococcal vaccines: facts versus fantasy.
Curr Opin Infect Dis. 2009 Dec;22(6):544-52. doi: 10.1097/QCO.0b013e328332bbfe.
3
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.
Lancet Infect Dis. 2009 Oct;9(10):611-6. doi: 10.1016/S1473-3099(09)70178-1.
4
emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development.
J Clin Microbiol. 2009 Aug;47(8):2502-9. doi: 10.1128/JCM.00312-09. Epub 2009 Jun 10.
5
Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
Clin Infect Dis. 2009 Jul 1;49(1):78-84. doi: 10.1086/599344.
6
Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes.
PLoS One. 2009;4(1):e4166. doi: 10.1371/journal.pone.0004166. Epub 2009 Jan 9.
7
Current status of group A streptococcal vaccine development.
Adv Exp Med Biol. 2008;609:53-63. doi: 10.1007/978-0-387-73960-1_5.
8
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.
Clin Infect Dis. 2007 Oct 1;45(7):853-62. doi: 10.1086/521264. Epub 2007 Aug 29.
9
Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
J Infect Dis. 2006 Aug 1;194(3):325-30. doi: 10.1086/505146. Epub 2006 Jun 20.
10
Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
Mol Microbiol. 2006 Jan;59(1):20-30. doi: 10.1111/j.1365-2958.2005.04913.x.
Zotero 插件